Despite HDAC1 being recognized as a co-factor of HDAC2 for transcriptional silencing47, studies have shown that their activation may also lead to distinct effects46,48,49, evidenced here by the observed mutual expression profile of HDAC1 and HDAC2 in GBM. The gene discussed is HDAC1; the disease is glioblastoma.